Step 1: Concept:
The question pertains to the history of vaccine development, specifically identifying the first vaccine produced using a modern bioinformatics technique known as "reverse vaccinology."
Step 2: Step-by-step Explanation:
• Reverse Vaccinology is a methodology that starts with the genomic sequence of a pathogen to computationally predict and identify novel antigens that are likely to invoke an immune response, rather than starting with the cultivation of the pathogen itself.
• Traditional methods failed to produce an effective vaccine against Neisseria meningitidis serogroup B (which causes meningitis) because its capsular polysaccharide is virtually identical to a human neural molecule, making it poorly immunogenic and risking autoimmunity.
• In 2000, Rino Rappuoli and his team used the genome sequence of MenB to identify novel surface proteins to use as vaccine targets.
• This groundbreaking work led to the development and licensure of the MenB vaccine (trade name Bexsero), officially making it the first licensed vaccine derived via reverse vaccinology.
Step 3: Final Answer:
The MenB vaccine is the correct answer, which corresponds to option (B).